Suppr超能文献

眼科医生的头痛:头痛理解和管理的最新进展。

Headache for ophthalmologists: current advances in headache understanding and management.

机构信息

Birmingham Neuro-Ophthalmology, University Hospitals Birmingham NHS Foundation Trust, B15 2TH, Birmingham, UK.

Department of Neurology, University Hospitals Birmingham NHS Foundation Trust, B15 2TH, Birmingham, UK.

出版信息

Eye (Lond). 2021 Jun;35(6):1574-1586. doi: 10.1038/s41433-021-01421-4. Epub 2021 Feb 12.

Abstract

Patients with headache and head pain are often referred to ophthalmologists. These symptoms can either be associated with underlying ophthalmic conditions, or more often are headache disorders unrelated to the eyes. Understanding the phenotype of the headache is critical for advice, safe discharge or onward referral. This review will provide an update on the criteria for common headache disorders that are often seen by ophthalmology and embrace disorders associated with ophthalmic diseases. It will also describe the changing management of migraine and outline recent therapies that are currently available.

摘要

经常有头痛和头部疼痛的患者被转诊至眼科医生处。这些症状可能与潜在的眼部疾病有关,或者更常见的是与眼睛无关的头痛疾病。了解头痛的表型对于提供建议、安全出院或进一步转诊至关重要。本综述将提供常见的眼科医生经常遇到的头痛疾病的标准的最新信息,并包括与眼部疾病相关的疾病。它还将描述偏头痛的治疗方法的变化,并概述目前可用的最新疗法。

相似文献

1
Headache for ophthalmologists: current advances in headache understanding and management.
Eye (Lond). 2021 Jun;35(6):1574-1586. doi: 10.1038/s41433-021-01421-4. Epub 2021 Feb 12.
2
Headache and the eye.
Curr Pain Headache Rep. 2008 Aug;12(4):296-304. doi: 10.1007/s11916-008-0050-1.
4
A standard optometric headache history.
J Am Optom Assoc. 1983 Feb;54(2):165-76.
5
Headache attributable to disorders of the eye.
Curr Pain Headache Rep. 2010 Feb;14(1):62-72. doi: 10.1007/s11916-009-0088-8.
6
The eye and headache.
Ophthalmol Clin North Am. 2004 Sep;17(3):357-69, vi. doi: 10.1016/j.ohc.2004.05.015.
7
An update on eye pain for the neurologist.
Neurol Clin. 2014 May;32(2):489-505. doi: 10.1016/j.ncl.2013.11.007. Epub 2014 Feb 28.
8
Child with Headache.
Indian J Pediatr. 2018 Jan;85(1):66-70. doi: 10.1007/s12098-017-2437-7. Epub 2017 Aug 30.
9
Vertiginous headache and its management.
Otolaryngol Clin North Am. 2014 Apr;47(2):333-41. doi: 10.1016/j.otc.2013.11.001. Epub 2014 Jan 29.
10
Neuro-ophthalmologic manifestations of primary headache disorders.
Semin Ophthalmol. 2008 May-Jun;23(3):169-77. doi: 10.1080/08820530802012937.

引用本文的文献

1
Managing idiopathic intracranial hypertension in the eye clinic.
Eye (Lond). 2024 Aug;38(12):2472-2481. doi: 10.1038/s41433-024-03140-y. Epub 2024 May 24.
2
Asymptomatic idiopathic intracranial hypertension: Prevalence and prognosis.
Clin Exp Ophthalmol. 2023 Aug;51(6):598-606. doi: 10.1111/ceo.14256. Epub 2023 May 27.
4
Giant cell arteritis: reviewing the advancing diagnostics and management.
Eye (Lond). 2023 Aug;37(12):2365-2373. doi: 10.1038/s41433-023-02433-y. Epub 2023 Feb 14.
5
Current Perspective on Retinal Migraine.
Vision (Basel). 2021 Aug 23;5(3):38. doi: 10.3390/vision5030038.
6
Current Perspectives on Idiopathic Intracranial Hypertension without Papilloedema.
Life (Basel). 2021 May 24;11(6):472. doi: 10.3390/life11060472.

本文引用的文献

1
Erenumab for headaches in idiopathic intracranial hypertension: A prospective open-label evaluation.
Headache. 2021 Jan;61(1):157-169. doi: 10.1111/head.14026. Epub 2020 Dec 14.
3
Reviewing the Recent Developments in Idiopathic Intracranial Hypertension.
Ophthalmol Ther. 2020 Dec;9(4):767-781. doi: 10.1007/s40123-020-00296-0. Epub 2020 Sep 9.
4
Photopsia.
Pract Neurol. 2020 Oct;20(5):415-419. doi: 10.1136/practneurol-2019-002460. Epub 2020 Jun 14.
5
Migraine and risk of stroke.
J Neurol Neurosurg Psychiatry. 2020 Jun;91(6):593-604. doi: 10.1136/jnnp-2018-318254. Epub 2020 Mar 26.
6
European Headache Federation recommendations for neurologists managing giant cell arteritis.
J Headache Pain. 2020 Mar 17;21(1):28. doi: 10.1186/s10194-020-01093-7.
8
A new era for giant cell arteritis.
Eye (Lond). 2020 Jun;34(6):1013-1026. doi: 10.1038/s41433-019-0608-7. Epub 2019 Oct 3.
9
Network Meta-Analysis of Calcitonin Gene-Related Peptide Receptor Antagonists for the Acute Treatment of Migraine.
Front Pharmacol. 2019 Jul 12;10:795. doi: 10.3389/fphar.2019.00795. eCollection 2019.
10
Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine.
N Engl J Med. 2019 Jul 11;381(2):142-149. doi: 10.1056/NEJMoa1811090.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验